EMERGENT BIOSOLUTIONS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
EMERGENT BIOSOLUTIONS INC. (EBS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.90 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 6.90M shares, a 2.82% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.70M shares, a 7.50% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 5.00M shares, a 92.31% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.10M shares, a 208.70% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.40M shares, a 10.20% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 4.90M shares, a 36.11% increase from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.60M shares, a 28.57% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.80M shares, a 180.00% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 6.90M shares 10-Q · filed 2026-08-06 | 5.30M shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 3.70M shares 10-Q · filed 2026-05-01 | |||
| 2025-12-31 | 4.40M shares 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 5.00M shares 10-Q · filed 2025-10-30 | 4.70M shares 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | 7.10M shares 10-Q · filed 2026-08-06 | 4.60M shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 4.00M shares 10-Q · filed 2026-05-01 | |||
| 2024-12-31 | 4.90M shares 10-K · filed 2026-02-27 | |||
| 2024-09-30 | 2.60M shares 10-Q · filed 2025-10-30 | 4.40M shares 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | 2.30M shares 10-Q · filed 2025-08-07 | 3.40M shares 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 4.50M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 3.60M shares 10-K · filed 2026-02-27 | |||
| 2023-09-30 | 4.00M shares 10-Q · filed 2024-11-07 | 3.60M shares 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | 3.60M shares 10-Q · filed 2024-08-07 | 3.40M shares 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | 3.20M shares 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | 2.80M shares 10-K · filed 2025-03-04 | |||
| 2022-09-30 | 3.30M shares 10-Q · filed 2023-12-11 | 2.60M shares 10-Q · filed 2023-12-11 | ||
| 2022-06-30 | 1.80M shares 10-Q · filed 2023-08-09 | 3.00M shares 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | 1.60M shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 1.00M shares 10-K · filed 2024-03-08 | |||
| 2021-09-30 | 1.40M shares 10-Q · filed 2022-11-09 | 600.00K shares 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | 1.40M shares 10-Q · filed 2022-08-02 | 500.00K shares 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | 100.00K shares 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | 0.00 shares 10-K/A · filed 2023-12-11 | |||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-05 | 0.00 shares 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | 400.00K shares 10-Q · filed 2021-07-30 | 600.00K shares 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | 700.00K shares 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | 900.00K shares 10-K · filed 2022-02-25 | |||
| 2019-09-30 | 1.00M shares 10-Q · filed 2020-11-06 | 1.00M shares 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | 3.00M shares 10-Q · filed 2020-07-31 | 3.00M shares 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | 3.10M shares 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | 0.00 shares 10-K · filed 2021-02-19 | |||
| 2018-03-31 | 3.20M shares 10-Q · filed 2019-05-08 | |||
| 2013-09-30 | 1.40M shares 10-Q · filed 2013-11-08 | 1.50M shares 10-Q · filed 2013-11-08 | ||
| 2013-03-31 | 5.00M shares 10-Q · filed 2013-05-03 | |||
| 2012-09-30 | 3.00M shares 10-Q · filed 2013-11-08 | 2.90M shares 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | 3.00M shares 10-Q · filed 2012-08-03 | 3.00M shares 10-Q · filed 2012-08-03 | ||
| 2012-03-31 | 4.50M shares 10-Q · filed 2013-05-03 | |||
| 2011-09-30 | 1.70M shares 10-Q · filed 2012-11-01 | 3.90M shares 10-Q · filed 2012-11-01 | ||
| 2011-06-30 | 719.00K shares 10-Q · filed 2012-08-03 | 4.00M shares 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |